Income Statement (TTM)
Nablus Surgical Center Company PLC Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6 | 5 | 5 | 6 | 6 | 7 | 7 | 7 | 7 | 7 | 6 | 6 | 6 | 6 | 5 | 5 | 5 | 4 | 5 |
| Change (%) | -11.04 | 0.41 | 9.55 | 0.05 | 12.56 | 2.22 | 1.31 | 1.03 | -3.72 | -2.65 | -4.41 | -0.60 | -4.84 | -11.78 | -2.55 | -7.49 | -5.89 | 12.79 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 1 | 2 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 3 | 3 |
| Change (%) | -11.11 | -0.62 | 1.51 | -4.62 | 4.89 | 1.37 | -4.50 | 2.22 | -4.58 | -7.21 | 2.84 | 87.35 | 27.31 | -64.75 | 0.61 | 3.50 | 164.05 | 7.19 | |
| % of Revenue | 29.00 | 28.98 | 28.68 | 26.58 | 25.33 | 23.61 | 23.41 | 22.07 | 22.33 | 22.13 | 21.09 | 22.69 | 42.77 | 57.23 | 22.87 | 23.61 | 26.42 | 74.11 | 70.43 |
| Gross Operating Profit | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 3 | 2 | 4 | 4 | 3 | 1 | 1 |
| Change (%) | -11.01 | 0.83 | 12.78 | 1.75 | 15.16 | 2.48 | 3.08 | 0.69 | -3.47 | -1.35 | -6.34 | -26.42 | -28.88 | 59.07 | -3.49 | -10.89 | -66.89 | 28.82 | |
| % of Revenue | 71.00 | 71.02 | 71.32 | 73.42 | 74.67 | 76.39 | 76.59 | 77.93 | 77.67 | 77.87 | 78.91 | 77.31 | 57.23 | 42.77 | 77.13 | 76.39 | 73.58 | 25.89 | 29.57 |
| SG&A | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 2 | 1 | 3 | 3 | 3 | 1 | 1 |
| Change (%) | -2.86 | 2.46 | 3.22 | 2.26 | 0.54 | 1.09 | -1.41 | 0.30 | -5.46 | -3.82 | -1.12 | -41.41 | -32.42 | 150.17 | 0.11 | -5.32 | -61.51 | -0.51 | |
| % of Revenue | 56.30 | 61.47 | 62.72 | 59.10 | 60.40 | 53.95 | 53.36 | 51.93 | 51.56 | 50.63 | 50.01 | 51.73 | 30.49 | 21.66 | 61.41 | 63.09 | 64.58 | 26.41 | 23.30 |
| R&D | |||||||||||||||||||
| Change (%) | |||||||||||||||||||
| % of Revenue | |||||||||||||||||||
| OpEx | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Change (%) | -5.39 | 1.69 | 2.85 | -0.43 | 2.68 | 1.11 | -2.24 | 0.84 | -4.86 | -4.51 | 0.08 | -2.68 | 2.26 | -4.14 | 0.80 | -2.30 | 1.79 | 5.08 | |
| % of Revenue | 89.36 | 95.04 | 96.25 | 90.36 | 89.92 | 82.03 | 81.15 | 78.31 | 78.16 | 77.23 | 75.76 | 79.32 | 77.66 | 83.46 | 90.68 | 93.81 | 99.06 | 107.15 | 99.82 |
| Operating Income | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | -0 | 0 |
| Change (%) | -58.50 | -24.11 | 181.35 | 4.62 | 100.71 | 7.25 | 16.58 | 1.70 | 0.37 | 3.68 | -18.44 | 7.36 | -29.54 | -50.32 | -35.23 | -86.02 | -818.88 | -102.85 | |
| % of Revenue | 10.64 | 4.96 | 3.75 | 9.64 | 10.08 | 17.97 | 18.85 | 21.69 | 21.84 | 22.77 | 24.24 | 20.68 | 22.34 | 16.54 | 9.32 | 6.19 | 0.94 | -7.15 | 0.18 |
| Interest Expense | -0 | -0 | -0 | -0 | -0 | ||||||||||||||
| Change (%) | 18.59 | 4,690.01 | 8.59 | ||||||||||||||||
| % of Revenue | -1.30 | -1.62 | -0.05 | -2.32 | -2.23 | ||||||||||||||
| Net Income | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 0 | -0 | -0 | -0 | -0 |
| Change (%) | -39.63 | -27.61 | 159.23 | 8.91 | 75.38 | 11.14 | 16.12 | 8.04 | -26.84 | 3.42 | -25.02 | -19.31 | 11.09 | -89.31 | -340.24 | 33.15 | 68.68 | -76.05 | |
| % of Revenue | 8.80 | 5.97 | 4.31 | 10.19 | 11.09 | 17.28 | 18.79 | 21.54 | 23.04 | 17.50 | 18.60 | 14.59 | 11.84 | 13.82 | 1.67 | -4.13 | -5.94 | -10.65 | -2.26 |
Source: Capital IQ
